AI-Powered Remote Drug Testing Breakthrough in Digital Health
Q2i as we speak introduced a collaboration with King’s College London (King’s) to judge its AI-powered expertise, which permits correct, distant drug testing for people in restoration from opioid use dysfunction.
Frequent in-person drug testing creates important limitations to care. Patients are sometimes required to go to clinics a number of occasions every week, a burden that may be overwhelming for these managing transportation difficulties, work schedules, or household obligations. While telehealth has expanded entry to therapy, drug testing—an integral part of restoration applications—has remained tough to manage outdoors of medical settings with the accuracy suppliers demand.
Q2i’s breakthrough expertise addresses this problem with AI-validated, at-home drug testing. Patients can full checks from house, whereas suppliers obtain safe, digitally noticed outcomes with the medical reliability wanted to help ongoing care. The system integrates seamlessly with telehealth and hybrid fashions, eradicating logistical hurdles that usually disrupt restoration.
“Drug testing has historically been a problem in digital well being applications,” stated Carol Ann Getty, lead researcher at King’s. “The newest advances in AI supply actual advantages for each medical groups and purchasers, significantly in phrases of pace and reliability in the case of digitally supervised testing. It’s an innovation that helps cut back limitations to care with out compromising medical requirements”.
In addition to testing, Q2i’s answer integrates contingency administration (CM), an evidence-based method that makes use of motivational incentives to encourage engagement, strengthen adherence to therapy plans, and help long-term restoration outcomes.
“We are delighted to work with King’s on this vital development,” stated Steven Jenkins, CEO of Q2i and recipient of the Excellence Awards CEO of the Year in Digital Health. “Our AI-powered expertise is enhancing entry in the U.S., and this collaboration underscores its worldwide relevance. With new workplaces in the UK, our CM division (CMI) is positioned to broaden throughout Europe.”
By combining safe, AI-driven drug testing with confirmed behavioral well being interventions, Q2i goals to get rid of one of many greatest obstacles to restoration. The expertise is designed to make therapy extra accessible, preserve sufferers related to care, and assist maintain restoration over the long run.
Q2i develops digital well being options that improve engagement, adherence, and outcomes. Its platforms combine evidence-based practices, AI expertise, and mobile-first design to make therapy extra accessible for sufferers and scalable for suppliers. Q2i’s CM division (CMI) is acknowledged as a world chief in digital contingency administration options.
The publish AI-Powered Remote Drug Testing Breakthrough in Digital Health first appeared on AI-Tech Park.
